Dynamic Healthcare M&A Database

Acquiring Party	Inverness Medical Innovations, Inc. (AMEX: IMA), a leading manufacturer of rapid diagnostic products for the consumer and professional markets, with a focus on women's health, cardiology and infectious disease.
Transferring Party	First Check Diagnostics LLC, a market leader of home testing for drugs of abuse.
Sector	Diagnostics
Date	January 28, 2007
Analysis First Check's tests can be conducted at home to detect drug abuse of substances such as marijuana, cocaine, methamphetamines, opiates and alcohol. The company also makes tests for cholesterol and colon cancer screening. Provides consumer-empowering tools for Inverness. Deal value -- $25m on sales of $11m (2.27x).
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.

Dynamic Healthcare M&A Database - 1Q07